5 Most Undervalued Quality Stocks to Invest In

3. Gilead Sciences Inc. (NASDAQ:GILD)

Number of Hedge Fund Holders: 77

Gilead Sciences Inc. (NASDAQ:GILD) is one of the most undervalued quality stocks to invest in. On June 2, Gilead Sciences announced positive Phase 3 IDEAL trial results for Livdelzi (seladelpar) in patients with primary biliary cholangitis/PBC. The study showed statistically significant improvements in composite alkaline phosphatase/ALP normalization compared with placebo after 52 weeks.

The trial evaluated patients with inadequately controlled PBC, including those with elevated ALP levels or intolerance to ursodeoxycholic acid/UDCA. Results demonstrated that a higher proportion of patients achieved sustained ALP normalization, with a safety profile consistent with previous studies and no new safety concerns identified.

Gilead said the findings strengthen evidence supporting ALP normalization as a key treatment goal in PBC and expand understanding of Livdelzi’s clinical benefit across a broader patient population. The company also noted that full results will be presented at an upcoming medical congress and shared with regulatory authorities for further review.

Gilead Sciences Inc. (NASDAQ:GILD) is a drug manufacturer that develops medicines for unmet medical needs. The company provides treatments for HIV-1, chronic hepatitis C, primary biliary cholangitis, chronic hepatitis B, and serious invasive fungal infections. It also offers T-cell and CAR T-cell therapies for adult patients, intravenous injections, and treatments for COVID-19.